Completed PHASE4 INTERVENTIONAL 1-arm NCT00678743

An Open-label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin

An Open-label Extension of a Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate Simvastatin 20 mg Plus Omacor 4g Compared to Simvastatin 20 mg Plus Placebo in Subjects With Mixed Dyslipidemia

Sponsor: Provident Clinical Research

Conditions Dyslipidemias

Interventions Omacor + simvastatin

Updated 7 times since 2017 Last updated: May 27, 2025 Started: Aug 31, 2007 Primary completion: Aug 31, 2009 Completion: Sep 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00678743, this PHASE4 trial focuses on Dyslipidemias and remains completed. Sponsored by Provident Clinical Research, it has been updated 7 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Jun 2025 — Present [monthly]

Completed PHASE4

Status: Unknown → Completed
Sep 2024 — Jun 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE4
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE4

First recorded

Aug 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Provident Clinical Research
Reliant Pharmaceuticals

Data source: Provident Clinical Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.